Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urethral Neoplasms × merphos × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Burkitt Lymphoma 20 Leukemia, Myeloid, Acute 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Myeloproliferative Disorders 5 Myelodysplastic Syndromes 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myelomonocytic, Chronic 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Hodgkin Disease 5 Congenital Abnormalities 5 Lymphoma, Large-Cell, Anaplastic 4 Leukemia, Myeloid, Accelerated Phase 4 Leukemia, Biphenotypic, Acute 4 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Hematologic Neoplasms 3 Chromosome 5q Deletion Syndrome 3 Breast Neoplasms 3 Blast Crisis 3 Anemia, Refractory, with Excess of Blasts 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Recurrence 2 Primary Myelofibrosis 2

Interventions

Gemcitabine 7 Cisplatin 5 Ramucirumab 3 Platinum 3 Paclitaxel 3 Docetaxel 3 1,2-diaminocyclohexaneplatinum II citrate 3 pembrolizumab 2 Carboplatin 2 rucaparib 1 pegfilgrastim 1 pazopanib 1 eribulin 1 enzalutamide 1 enfortumab vedotin 1 dehydroftorafur 1 cabozantinib 1 avelumab 1 atezolizumab 1 aflibercept 1 Taxes 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1 Specimen Handling 1 Sorafenib 1 Radiotherapy 1 Radiation 1 N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide 1 Mitozytrex 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡